Overview

Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Liver Cirrhosis is a common pathological consequence of chronic liver disease. Hepatitis B Virus (HBV) is one of most etiologies of liver cirrhosis in China. The effective inhibition of HBV can partially stop or reverse liver fibrosis in patients with chronic Hepatitis and liver cirrhosis due to HBV, and the anti-fibrotic strategy focusing on the regulation of hepatic extracellular matrix is still required and hopefully improve the efficacy of anti-virals for liver fibrotic patients with HBV, especially is necessary for in the patients with advance fibrosis stage ie. liver cirrhosis. Fuzheng Huayu has been found to enhance the degradation of collagens in fibrotic liver and have a good action against liver fibrosis in patients with chronic hepatitis B. However, there are no high quality clinical evidences which can demonstrate if the combination of anti-viral and anti-fibrotic therapy can improve the reversion of liver cirrhosis due to HBV. The primary objective of this study is to establish the safety and efficacy of the combination of Entecavir and Fuzheng Huayu for the reversion of liver fibrosis in patients with liver cirrhosis due to HBV.
Phase:
Phase 4
Details
Lead Sponsor:
ShuGuang Hospital
Collaborators:
Affiliated Hospital of Shandong Univercity of TCM
Beijing Ditan Hospital
Beijing YouAn Hospital
China-Japan Friendship Hospital
Fifth Hospital of Shijiazhuang City
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Guangxi Ruikang Hospital
Huai'an No. 4 People's Hospital
Hubei Hospital of Traditional Chinese Medicine
Jingmen No.1 People's Hospital
Jingmen No.1 People’s Hospital
Ruijin Hospital
Shandong University of Traditional Chinese Medicine
Shanghai Zhongshan Hospital
Shenzhen Third People's Hospital
The Fifth People's Hospital of Anyang
The Fifth People's Hospital of Suzhou
The Fifth People’s Hospital of Anyang
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
The Ninth Hospital of Nanchang
The People's Hospital of Ningxia
Tongji Hospital
Wenzhou Central Hospital
Treatments:
Entecavir